0 14

Cited 0 times in

Cited 0 times in

A comparative study on stevioside-and rubusoside-assisted micellar solubilization of clofazimine for physicochemical and in vitro release properties

DC Field Value Language
dc.contributor.authorHong, Seong-Jin-
dc.contributor.authorAn, Hye-Su-
dc.contributor.authorPark, Bo-Ram-
dc.contributor.authorYoon, Ki-Nam-
dc.contributor.authorKang, Hye-Jin-
dc.contributor.authorShin, Sung Jae-
dc.contributor.authorKim, Young-Min-
dc.date.accessioned2025-12-26T03:00:42Z-
dc.date.available2025-12-26T03:00:42Z-
dc.date.created2025-12-11-
dc.date.issued2025-12-
dc.identifier.issn2590-1567-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/209658-
dc.description.abstractThis study compares the micellization and encapsulation abilities of stevioside (STE) and rubusoside (RUB) for enhancing the solubility, stability, and bioavailability of clofazimine (CFZ), a poorly water-soluble antibiotic. CFZ-loaded micelles were prepared and characterized by FT-IR, XRD, DSC, SEM, and NMR. RUB showed a lower critical micelle concentration and significantly improved CFZ solubility (up to 2.06 mg/mL) compared to STE. CFZ-RUB complexes offered greater protection against UV and oxidative degradation. In vitro release tests indicated sustained and enhanced CFZ release in simulated gastrointestinal fluids. CFZ-RUB also showed higher permeability across Caco-2 cell monolayers (62.5 %) and reduced cytotoxicity versus free CFZ. These results suggest that RUB's amphiphilic structure facilitates stable micelle formation and efficient drug loading. Overall, RUB presents a promising natural solubilizer and oral delivery vehicle for lipophilic bioactives in food and pharmaceutical applications, providing new insights into the structure-function roles of steviol glycosides.-
dc.language영어-
dc.publisherELSEVIER-
dc.relation.isPartOfINTERNATIONAL JOURNAL OF PHARMACEUTICS-X-
dc.titleA comparative study on stevioside-and rubusoside-assisted micellar solubilization of clofazimine for physicochemical and in vitro release properties-
dc.typeArticle-
dc.contributor.googleauthorHong, Seong-Jin-
dc.contributor.googleauthorAn, Hye-Su-
dc.contributor.googleauthorPark, Bo-Ram-
dc.contributor.googleauthorYoon, Ki-Nam-
dc.contributor.googleauthorKang, Hye-Jin-
dc.contributor.googleauthorShin, Sung Jae-
dc.contributor.googleauthorKim, Young-Min-
dc.identifier.doi10.1016/j.ijpx.2025.100424-
dc.identifier.pmid41230037-
dc.subject.keywordClofazimine-
dc.subject.keywordStevioside-
dc.subject.keywordRubusoside-
dc.subject.keywordMicelle-
dc.subject.keywordRelease properties-
dc.contributor.affiliatedAuthorAn, Hye-Su-
dc.contributor.affiliatedAuthorShin, Sung Jae-
dc.identifier.scopusid2-s2.0-105020982108-
dc.identifier.wosid001608606100002-
dc.citation.volume10-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF PHARMACEUTICS-X, Vol.10, 2025-12-
dc.identifier.rimsid90371-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorClofazimine-
dc.subject.keywordAuthorStevioside-
dc.subject.keywordAuthorRubusoside-
dc.subject.keywordAuthorMicelle-
dc.subject.keywordAuthorRelease properties-
dc.subject.keywordPlusBETA-GLUCOSIDASE-
dc.subject.keywordPlusDRUGS-
dc.subject.keywordPlusCYCLODEXTRIN-
dc.subject.keywordPlusENHANCEMENT-
dc.subject.keywordPlusIMPROVE-
dc.subject.keywordPlusSTEVIA-
dc.type.docTypeArticle-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.identifier.articleno100424-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.